Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,717 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia).
Seino Y, Min KW, Niemoeller E, Takami A; EFC10887 GETGOAL-L Asia Study Investigators. Seino Y, et al. Diabetes Obes Metab. 2012 Oct;14(10):910-7. doi: 10.1111/j.1463-1326.2012.01618.x. Epub 2012 May 30. Diabetes Obes Metab. 2012. PMID: 22564709 Free PMC article. Clinical Trial.
Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study).
Lim S, Han KA, Yu J, Chamnan P, Kim ES, Yoon KH, Kwon S, Moon MK, Lee KW, Kim DJ, Kim M, Wongtanate M, Kim EY, Kim SH, Lee MK; INICOM Study Group. Lim S, et al. Among authors: kim ey, kim sh, kim dj, kim m, kim es. Diabetes Obes Metab. 2017 Jan;19(1):87-97. doi: 10.1111/dom.12787. Epub 2016 Oct 14. Diabetes Obes Metab. 2017. PMID: 27619558 Free PMC article. Clinical Trial.
Teneligliptin versus sitagliptin in Korean patients with type 2 diabetes inadequately controlled with metformin and glimepiride: A randomized, double-blind, non-inferiority trial.
Kim Y, Kang ES, Jang HC, Kim DJ, Oh T, Kim ES, Kim NH, Choi KM, Kim SR, You J, Kim SJ, Lee MK. Kim Y, et al. Among authors: kim sr, kim dj, kim sj, kim nh, kim es. Diabetes Obes Metab. 2019 Mar;21(3):631-639. doi: 10.1111/dom.13566. Epub 2018 Nov 22. Diabetes Obes Metab. 2019. PMID: 30362280 Free PMC article. Clinical Trial.
A report on the diagnosis of intermediate hyperglycemia in Korea: A pooled analysis of four community-based cohort studies.
Oh JY, Lim S, Kim DJ, Kim NH, Kim DJ, Moon SD, Jang HC, Cho YM, Song KH, Ahn CW, Sung YA, Park JY, Shin C, Lee HK, Park KS; Committee of the Korean Diabetes Association on the Diagnosis and Classification of Diabetes Mellitus. Oh JY, et al. Among authors: kim dj, kim nh. Diabetes Res Clin Pract. 2008 Jun;80(3):463-8. doi: 10.1016/j.diabres.2008.01.022. Epub 2008 Mar 12. Diabetes Res Clin Pract. 2008. PMID: 18339440
3,717 results